Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial.

[1]  L. Lynen,et al.  Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial. , 2021, The Lancet. Infectious diseases.

[2]  M. Unemo,et al.  Gonorrhoea , 2019, Nature Reviews Disease Primers.

[3]  C. Fairley,et al.  Sites in the oropharynx reached by different methods of using mouthwash: clinical implication for oropharyngeal gonorrhoea prevention , 2019, Sexually Transmitted Infections.

[4]  J. Hocking,et al.  Models of gonorrhoea transmission from the mouth and saliva. , 2019, The Lancet. Infectious diseases.

[5]  A. Spychała,et al.  The development of mouthwashes without anti-gonococcal activity for controlled clinical trials: an in vitro study , 2019, F1000Research.

[6]  I. Martin,et al.  World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. , 2019, Sexual health.

[7]  C. Fairley,et al.  Trends and Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018 , 2019, Antimicrobial Agents and Chemotherapy.

[8]  C. Fairley,et al.  The role of saliva in gonorrhoea and chlamydia transmission to extragenital sites among men who have sex with men: new insights into transmission , 2019, Journal of the International AIDS Society.

[9]  C. Fairley,et al.  Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV. , 2019, The lancet. HIV.

[10]  J. Hocking,et al.  Kissing may be an important and neglected risk factor for oropharyngeal gonorrhoea: a cross-sectional study in men who have sex with men , 2019, Sexually Transmitted Infections.

[11]  J. Hocking,et al.  Evidence for a new paradigm of gonorrhoea transmission: cross-sectional analysis of Neisseria gonorrhoeae infections by anatomical site in both partners in 60 male couples , 2019, Sexually Transmitted Infections.

[12]  J. D. de Wit,et al.  Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013-17. , 2018, The lancet. HIV.

[13]  A. Nardone,et al.  100 years of STIs in the UK: a review of national surveillance data , 2018, Sexually Transmitted Infections.

[14]  C. Fairley,et al.  New thinking on gonorrhoea control in MSM: are antiseptic mouthwashes the answer? , 2018, Current opinion in infectious diseases.

[15]  J. Kwong,et al.  Whole-genome sequencing reveals transmission of gonococcal antibiotic resistance among men who have sex with men: an observational study , 2017, Sexually Transmitted Infections.

[16]  C. Fairley,et al.  Self-Reported Use of Mouthwash and Pharyngeal Gonorrhoea Detection by Nucleic Acid Amplification Test , 2017, Sexually transmitted diseases.

[17]  J. Hocking,et al.  Sexually Transmitted Infections in Melbourne, Australia from 1918 to 2016: nearly a century of data. , 2017, Communicable diseases intelligence quarterly report.

[18]  Suzanna C Francis,et al.  Sexually transmitted infections: challenges ahead. , 2017, The Lancet. Infectious diseases.

[19]  J. Kaldor,et al.  A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol , 2017, BMC Infectious Diseases.

[20]  C. Fairley,et al.  Increased Detection of Pharyngeal and Rectal Gonorrhea in Men Who Have Sex With Men After Transition From Culture To Nucleic Acid Amplification Testing , 2017, Sexually transmitted diseases.

[21]  C. Fairley,et al.  Antiseptic mouthwash against pharyngeal Neisseria gonorrhoeae: a randomised controlled trial and an in vitro study , 2016, Sexually Transmitted Infections.

[22]  Monica Lahra,et al.  From zero to zero in 100 years: gonococcal antimicrobial resistance , 2016 .

[23]  S. Tabrizi,et al.  Neisseria gonorrhoeae Bacterial DNA Load in the Pharynges and Saliva of Men Who Have Sex with Men , 2016, Journal of Clinical Microbiology.

[24]  J. Hocking,et al.  Saliva use as a lubricant for anal sex is a risk factor for rectal gonorrhoea among men who have sex with men, a new public health message: a cross-sectional survey , 2016, Sexually Transmitted Infections.

[25]  J. Hocking,et al.  Detection of Neisseria gonorrhoeae Isolates from Tonsils and Posterior Oropharynx , 2015, Journal of Clinical Microbiology.

[26]  Morgen M. Miller,et al.  Computing Adjusted Risk Ratios and Risk Differences in Stata , 2013 .

[27]  J. Kaldor,et al.  Prevalence, incidence and risk factors for pharyngeal gonorrhoea in a community-based HIV-negative cohort of homosexual men in Sydney, Australia , 2009 .

[28]  S. Hafiz,et al.  Inhibition of Neisseria gonorrhoeae by normal human saliva. , 1979, The British journal of venereal diseases.

[29]  M. Unemo,et al.  Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea. , 2019, Methods in molecular biology.

[30]  D. Brogan,et al.  American Journal of Epidemiology Practice of Epidemiology Estimating Model-adjusted Risks, Risk Differences, and Risk Ratios from Complex Survey Data , 2022 .